Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 3Terminated 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

CNS 10Breast 9Gastrointestinal 5Thoracic 4Other hematologic neoplasm 4Tumor-Agnostic 3Sarcoma 3Lymphoid 3Genitourinary 2Plasma cell 1Other solid neoplasm 1Myeloid 1Head & Neck 1Gynecologic 1Dermatologic 1

Conditions

Neoplasms 3

Interventions

Paclitaxel 57Gemcitabine 51Carboplatin 51Surveys and Questionnaires 48Docetaxel 37Bevacizumab 37pembrolizumab 33Nivolumab 29Cisplatin 28Fluorouracil 24Capecitabine 23Irinotecan 22Erlotinib Hydrochloride 22Sorafenib 20Leucovorin 19Afatinib 19Radiotherapy 18Pemetrexed 18Oxaliplatin 17Trastuzumab 16Ipilimumab 15regorafenib 14Blood Specimen Collection 14130-nm albumin-bound paclitaxel 14olaparib 13Interviews as Topic 13Cetuximab 13Albumin-Bound Paclitaxel 13atezolizumab 12Sunitinib 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Mental Status and Dementia Tests × Tumor-Agnostic × Clear all
NCT01506440 2018-07-03

Cognitive Assessments in Patients With Cancer Undergoing Chemotherapy

Wake Forest University Health Sciences

Completed
29 enrolled
Tumor-Agnostic

Neoplasms

NCT02558907 2017-04-04

MoCA

Centre Francois Baclesse

Completed
66 enrolled
Tumor-Agnostic

Neoplasms

NCT03052868 2017-02-14

Analysis of Neurocognitive Elements of Attention After Chemotherapy

University of Texas Southwestern Medical Center

Phase NA Completed
75 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡